The Competition Between Endogenous Dopamine and Radioligands for Specific Binding to Dopamine Receptors
- 1 June 2002
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 965 (1) , 440-450
- https://doi.org/10.1111/j.1749-6632.2002.tb04185.x
Abstract
The ternary complex model of G‐protein‐linkage to receptors holds that agonists increase the affinity of the receptors for the G protein. Consequently, an agonist can exert the greatest inhibition of the binding of radioligands which are also agonists. We hypothesized that competition from endogenous dopamine in striatum of living mice should thus have a greater effect on the binding of the D2,3 agonist N‐[3H]propylnorapomorphine ([3H]NPA), than on the binding of the D2,3 antagonist [11C]raclopride in living brain. The binding potential (pB(0)), defined as the ratio of bound‐to‐unbound ligand after reserpine treatment, was measured in mouse striatum for [11C]raclopride, and for [3H]NPA. Relative to these baseline values after dopamine depletion, saline‐treatment decreased the pB of [3H]NPA by one‐half, while the pB of [11C]raclopride declined by only one‐third. Amphetamine decreased the pB of [3H]NPA to a greater extent than that of [11C]raclopride. The apparent inhibition constant of endogenous dopamine depended on the dopamine occupancy and declined to a value 1.66 times greater for [3H]NPA than for [11C]raclopride at its highest occupancies. Thus, the agonist binding was more sensitive than antagonist binding to competition from endogenous dopamine. Dopamine agonist ligands may be especially useful for PET studies of dopamine receptor occupancy by endogenous synaptic dopamine. Analysis of the effect of dopamine occupancy on the inhibition of agonist indicated a limited supply of G protein, with a maximum ternary complex fraction of 40% of maximum antagonist binding capacity.Keywords
This publication has 24 references indexed in Scilit:
- (−)-N-[11C]propyl-norapomorphine: a positron-labeled dopamine agonist for PET imaging of D2 receptorsNuclear Medicine and Biology, 2000
- Effect of reserpine-induced depletion of synaptic dopamine on [11C]Raclopride binding to D2-dopamine receptors in the monkey brainSynapse, 1997
- Quantification of Amphetamine-Induced Changes in [11C]Raclopride Binding with Continuous InfusionJournal of Cerebral Blood Flow & Metabolism, 1997
- Comparison of Methods for Analysis of Clinical [11C]Raclopride StudiesJournal of Cerebral Blood Flow & Metabolism, 1996
- Striatal binding of the PET ligand 11C‐raclopride is altered by drugs that modify synaptic dopamine levelsSynapse, 1993
- Effects of endogenous dopamine on kinetics of [3H]N‐methylspiperone and [3H]raclopride binding in the rat brainSynapse, 1991
- Difference in in vivo receptor binding between [3 H]N-methylspiperone and [3 H]raclopride in reserpine-treated mouse brainJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1991
- In vivo binding of N-n-propylnorapomorphine in the rat brain: Regional localization, quantification in striatum and lack of correlation with dopamine metabolismEuropean Journal of Pharmacology, 1983
- Interaction at end-plate receptors between different choline derivativesProceedings of the Royal Society of London. B. Biological Sciences, 1957